Found 46 matching trials
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
PHASE2Persons diagnosed with thyroid cancer are often treated initially with a th...
Location
University of California, San Francisco
Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
PHASE2The goal of this research study is to determine whether changes in organ-sp...
Location
University of Tennessee Graduate School of Medicine
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
PHASE2This was a single center, prospective cohort study that is evaluating the a...
Location
Columbia University Irving Medical Center
A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis
PHASE1This is a single center Phase 1 study is to evaluate the biodistribution of...
Location
University of Tennessee Medical Center
Radioimmunoimaging of AL Amyloidosis
PHASE1The purpose of the study is to determine the capability of a radiolabeled a...
Location
University of Tennessee Medical Center
Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal
NAThis research study is to compare the radiopharmacokinetics of I-124 to the...
Location
Washington Hospital Center
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
PHASE2Study rationale
High risk patients with differentiated thyroid cancer (DTC...
Location
National Institutes of Health Clinical Center
PET Evaluation of Recurrent Differentiated Thyroid Cancer
N/AAfter initial treatment of differentiated thyroid cancer patients (DTC) are...
Location
Rijnstate Hospital
Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
PHASE2Progressive and metastatic thyroid cancer patients, who no longer respond t...
Location
National University Hospital
NM404 as an Imaging Agent in Patients With NSCLC
PHASE1This study seeks to determine imaging characteristics of radiolabelled 131-...
Location
University of Wisconsin Carbone Comprehensive Cancer Center